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Identifying the genes that cause disease is one of the most challenging issues to establish the diagnosis
and treatment quickly. Several interesting methods have been introduced for disease gene identiﬁcation
for a decade. In general, the main differences between these methods are the type of data used as a
prior-knowledge, as well as machine learning (ML) methods used for identiﬁcation. The disease gene
identiﬁcation task has been commonly viewed by ML methods as a binary classiﬁcation problem
(whether any gene is disease or not). However, the nature of the data (since there is no negative data
available for training or leaners) creates a major problem which affect the results. In this paper,
sequence-based, one class classiﬁcation method is introduced to assign genes to disease class (yes, no).
First, to generate feature vector, the sequences of proteins (genes) are initially transformed to numerical
vector using physicochemical properties of amino acid. Second, as there is no deﬁnite approach to deﬁne
non-disease genes (negative data); we have attempted to model solely disease genes (positive data) to
make a prediction by employing Support Vector Data Description algorithm. The experimental results
conﬁrm the efﬁciency of the method with precision, recall and F-measure of 79.3%, 82.6% and 80.9%,
respectively.
 2015 Elsevier Inc. All rights reserved.1. Introduction
Identifying disease genes is an important issue to enhance our
knowledge about disease mechanism, and to improve clinical
methods.
Traditional linkage and association studies have been carried
out to identify a large number of candidate genes probably related
with diseases [1]. Since using experimental approaches to identify
disease associated genes from the vast numbers of candidates is an
expensive task, the requirement of computational approaches has
been taken into account. In this regard, many interesting machine
learning methods have been introduced to ﬁnd the similarity fea-
tures between unknown genes (candidate genes) with the known
disease genes. These methods differ in two ways. First, the type
of genomic data used for generating the feature vector, such as pro-
tein–protein interactions (PPIs) [2–6], gene expression proﬁles [7],
gene ontology (GO) [8]. Other methods integrate multiple data
sources to prioritize candidate disease genes [9–11].
Second, the type of the algorithmwhich has been used for train-
ing the prediction model. However, the majority of the studiesconsider this issue as two class classiﬁcation problem. Some studies
have deﬁned the known disease gene as positive set and the
unknown disease gene as negative set [12,13]. Since the unknown
genes set is often comprised with some disease genes, other meth-
ods have attempted to reduce the confusion in classiﬁcation process
by selecting a small fraction of unknown genes as negative set
[14,15]. Nevertheless, these methods are not robust and reliable
enough as the negative set which has been achieved from unknown
genes, still suffers from noisy data.
All the above mentioned methods might not be implemented
properly, because these methods rely on the information of pro-
teins achieved from prior-knowledge (PPI network, gene ontology,
and protein domains) which contains some errors. Moreover, they
usually suffer from incompleteness. Therefore, a universal
prior-knowledgewould be required to tackle this problem. The only
data which are available for all proteins and has inﬂuential role in
solving many problems such as predicting a subcellular locations
[16,17], protein–protein interactions [18–20], and protein struc-
tural and functional classes [21–23] is the sequences of proteins
[24]. On the other hand, there is no information about the negative
data (non-disease gene). Also, there is no guarantee of using the
unknown genes or fraction of them as a negative data. Hence, using
two class classiﬁcation algorithm may be not appropriate.
A. Yousef, N.M. Charkari / Journal of Biomedical Informatics 56 (2015) 300–306 301In this paper, we present a novel sequence-based one class classi-
ﬁcationmethod for disease gene identiﬁcation. Since the earliest pro-
tein sequences and the structureswere determined, itwould be clear
that the positioning and properties of amino acids are key point to
infer many biological processes. For example, the ﬁrst protein struc-
ture, haemoglobin provides a molecular explanation for the genetic
disease sickle cell anaemia [25]. Therefore, a sequence-translated
method based on physicochemical properties of amino acid, is
employed to construct a feature vector for each protein. To improve
the performance of the proposed method, some efﬁcient features
are selected using Principal Component Analysis (PCA). Since, the
mutation of genes is always possible to happen, and also there is a
likelihood of this mutation leading to disease [26], there is no avail-
able conception asserts that someproteins are not involved indisease
(non-disease genes). Hence, we have attempted to only train the pos-
itive data (disease genes) using Support Vector Data Description
(SVDD) algorithm. We have used two type of data as negative data
to evaluate the model. The ﬁst type has selected randomly from
unknown dataset. While the second one has been selected from the
likely negative data used in positive-unlabeled technique [15].
The proposed method has been compared with ProDiGe
method [14], Smalter’s method [12], and yang method [15].
The experimental results achieved 79.3%, 82.6% and 80.9%
for precision, recall and F-measure, respectively. These results
indicate that our method overpassed the current state-of-the
art methods in precision.
2. Material and method
In this section, the proposed method for identifying disease
genes is described. The method consists of three steps: (1)
Translate corresponding gene products (proteins) into numerical
feature vector using physicochemical descriptor; (2) Principal
Component Analysis (PCA) algorithm is applied to extract appro-
priate features; (3) training the positive data using SVDD algorithm
to make the identiﬁcation. The proposed method schema is illus-
trated in Fig. 1.2.1. Protein sequence translation
Many representation methods have been introduced to extract
the information encoded in amino acid sequence, including GearyFig. 1. The schematic of the proposed method. As is shown, the proposed method inclu
layer.auto correlation (GA) [27], auto covariance (AC) [28], Normalized
Moreau–Broto autocorrelation (NA) [29], and Moran
auto-correlation (MA) [30]. These methods are based on different
physicochemical properties. In this paper, six joint physicochemi-
cal properties of amino acid which were used in many applications
(e.g. predicting protein structural, functional classes, protein–pro-
tein interactions, sub-cellular locations. . .) have been selected.
Since by adding one more physicochemical property, thirty fea-
tures will be added to the feature vector, we have selected out
the more effective physicochemical properties with the minimum
number of these properties to avoid complexity (Time, and
Computation). These properties are polarity (POL) [31], residue
accessible surface area in tripeptide (RAS) [32], hydrophilicity
(HY-PHIL) [33], polarizability (POL2) [34], hydrophobicity
(HY-PHOB) [35], solvation free energy (SFE) [36], respectively.
The original values of these physicochemical properties for each
amino acid were normalized using Min–Max normalization
method as shown in Eq. (1):
Pij ¼ Pi;j  Pj;minPj;Max  Pj;min ð1Þ
where Pi;j is the j-th descriptor value for i-th amino acid, Pj;min is the
minimum value of j-th descriptor over the 20 amino acids and Pj;Max
is the maximum value of j-th descriptor over the 20 amino acids.
Table 1 shows the normalized physicochemical properties. Since
GA method has achieved a good result in other application [20], in
this work, we have applied GA method as a representation method.2.2. Principal Component Analysis (PCA)
To increase the overall performance of the proposedmethod, we
tried to extract the most relevant and useful features from the
high-dimensional represented feature vectors (180 features) gener-
ated by GA method. PCA is presented as a dimensionality reduction
methods. PCA is an appropriate statistical technique to identify pat-
terns in data, and to expiree the data in away that to high light their
similarities and differences. Therefore, utilized to determine signif-
icant featureswhich preservesmost of the information and removes
the redundant components [37]. PCA is a linear combination which
transforms one set of variables in Rm space into another set in Rn
space containing the maximum amount of variance in the data
where n is smaller thanm. This is obtained as the following steps:des three layers which are representation layer, Feature extraction layer, predictor
Table 1
The normalized value of six physicochemical properties for each of Amino Acid (A–Y).
HY-PHOB HY-PHIL POL POL2 SFE RAS
A 0.281 0.453 0.395 0.112 0.589 0.222
C 0.458 0.375 0.074 0.312 0.527 0.333
D 0 1 1 0.256 0.191 0.416
E 0.027 1 0.913 0.369 0.285 0.638
F 1 0.14 0.037 0.709 0.936 0.75
G 0.198 0.531 0.506 0 0.446 0
H 0.207 0.453 0.679 0.562 0.582 0.666
I 0.792 0.25 0.037 0.454 0.851 0.555
K 0.198 1 0.79 0.535 0.325 0.694
L 0.783 0.25 0 0.454 0.851 0.527
M 0.721 0.328 0.098 0.54 0.957 0.611
N 0.12 0.562 0.827 0.327 0.319 0.472
P 0.253 0.531 0.382 0.32 0.702 0.388
Q 0.123 0.562 0.691 0.44 0.4 0.583
R 0.222 1 0.691 0.711 0 0.833
S 0.235 0.578 0.53 0.151 0.448 0.222
T 0.318 0.468 0.456 0.264 0.557 0.361
V 0.687 0.296 0.123 0.342 0.765 0.444
W 0.56 0 0.061 1 1 1
Y 0.922 0.171 0.16 0.728 0.787 0.861
Fig. 2. Support Vector Data Description sketch-ma.
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N
XN
k¼0
ðxk mÞ xk mð ÞT ;where m ¼ 1N
PN
k xk, the mean of the original feature vectors.
2. Compute the eigenvectors and eigenvalues of the covariance
matrix by solving the following decomposition
kiei ¼ Sei;where kiis the eigenvalue associated with the eigenvector ei.
3. Sort the result in decreasing order of eigenvalue.
4. Choose the most important components (features).
2.3. Support Vector Data Description (SVDD)
Since there is no information about the negative data
(non-disease gene) and solely the positive data (target data) is
available, one class classiﬁcation (OCC) method would be the
proper approach to efﬁciently solve the disease gene identiﬁcation
problem. The OCC method makes a description of a disease gene
set and detects new genes to resemble this set. Support Vector
Data Description (SVDD) method is inspired by support vector
machine which has used for novelty or outlier detection. it is a
one-class classiﬁcation that constructs a hyper-sphere by enclosing
the target instances properly to assign a test instance to positive
class or not [38]. The objective of SVDD is to ﬁnd a minimum
hyper-sphere with center a and radius R, including all the target
instances. Fig. 2 shows the SVDD method sketch-ma. SVDD algo-
rithm like SVM algorithm provides more ﬂexible and stable
description of the boundary by applying kernel functions (e.g.
Gaussian kernel). For disease gene identiﬁcation, SVDD has the fol-
lowing beneﬁts [38]:
1. Sparsity: fewer training samples are needed. As we mentioned
above, a small fraction of genes would be predicted as disease
gene.
2. Good generalization: SVDD method avoids overfitting and yields
good generalization results when compared with other conven-
tional methods.
3. Use of kernels: by exploiting the ‘kernel trick’, the SVDD method
is able to accurately model the support of non-trivial,
multi-modal distributions.3. Results
At ﬁrst, we have evaluated the effect of different sequence rep-
resentation methods on the performance of the proposed method.
Furthermore, the best number of features extracted by PCA algo-
rithm for each of these methods has been investigated. After
selecting the most effective sequence representation method, we
have assessed the impact of each physicochemical properties of
amino acid on the identiﬁcation process. Finally, to conﬁrm the
efﬁciency of the method, we have conducted the comparison
between our method and the state-of-the-art techniques on gen-
eral disease genes identiﬁcation.
3.1. Experimental data
The data used by [15] has been employed in our experiments.
This dataset consists of 5405 known disease genes (positive data)
spanning 2751 disease phenotypes, where all the genes have been
extracted by combining GENECARD [39] and OMIM [40] disease
gene data. In addition 16 k genes from Ensembl [41] has been
selected as the unknown gene set.
3.2. Evaluation metrics
To measure the performance of the proposed identiﬁcation
method, different metrics have been used. The Recall, Precision,
and F-measure which are deﬁned as follows:
Recall ¼ TP
TPþ FN
Precision ¼ TP
TPþ FP
F-measure ¼ 2  Recall  Precision
Recallþ Precision
where FP is false positive (non-disease genes ‘negative data’ which
have been identiﬁed as disease gene), TP is True Positive (disease
genes which have been correctly identiﬁed), and FN is false negative
(disease genes which have been identiﬁed as non-disease gene ‘neg-
ative data’ not correctly). The Recall is the ratio of the number of
disease genes retrieved to the total number of disease genes in
the dataset. Precision is the ratio of the number of relevant disease
genes retrieved to the total number of irrelevant and relevant dis-
ease genes retrieved. Finally, the F-measure is the harmonic mean
of recall and precision.
Table 3
Comparison between sequence representation methods using PCA extracted features.
Methods # of PCA Features Precision (%) Recall (%) F-measure (%)
AC-SVDD 55 78.6 74.2 76.3
GA-SVDD 60 79.3 82.6 80.9
NA-SVDD 80 76.1 81.2 78.5
MA-SVDD 55 72 80.4 75.9
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In order to minimize the overﬁtting of the identiﬁcation model,
5-fold cross-validations has been carried out in all of the experi-
ments. 5000 positive and 5000 unlabeled instances have been
employed. Since, the disease genes are available, we used SVDD
which requires only positive data for training. For testing and esti-
mating the error rates, some negative data would be required. In
this regard, we have employed two evaluation strategies. In The
ﬁrst strategy, some of unknown data have been selected randomly
as negative data and have been used in testing process. In the sec-
ond strategy, we have used positive-unlabeled method [15] which
considered the farthest unknown instances from the mean vector
of the all positive data as negative instances.Fig. 3. The effectiveness of physicochemical properties on the disease gene
identiﬁcation.
Table 44.1. Performance of the sequence representation methods
To evaluate the robustness of the representation methods, we
have attempted to train and test the model using SVDD algorithm
based on AC, GA, MA, NA representation methods separately. The
results of each predicator have been reported in two ways. First,
the results when all the features have been employed. Second,
the new results when the PCA feature reduction method have been
employed.
Table 2 shows the comparison between the identiﬁcation per-
formances of the sequence representation method using all fea-
tures. Table 3 indicates the results of each representation method
after applying the PCA feature reduction method. It can be found
that the performance of the GA method is better than the perfor-
mance of the other ones. Therefore, we select the GA as the main
sequence representation method for the next experiments.
Moreover, Table 3 indicates the positive effect of using PCA in
improving the experimental results.Comparative evaluation between different one class classiﬁcation methods.
Methods Precision (%) Recall (%) F-measure (%)
SVDD 79.3 82.6 80.9
Parzen 79.6 80.3 79.9
Mixture of Gaussian 79.2 81.5 80.34.2. Assessment of physicochemical properties
Since the sequence representation method is based on the
physicochemical properties, in this experiment, our objective is
to understand which physicochemical property has more impact
in identiﬁcation disease gene. In this regard, six different GA fea-
ture vectors have been built. The ﬁrst one is generated using all
physicochemical properties, and the ﬁve other ones are generated
by deleting one of the physicochemical properties, respectively. In
this experiment, we could observe that the deletion of the HY-PHIL
property reduces the F-measure dramatically. While, deleting the
others has a small negative effect on the performance. Fig. 3 illus-
trates the priority of physicochemical properties in disease gene
identiﬁcation. However, the deletion of any physicochemical prop-
erties will decrease the performance.4.3. Evaluation of different One Class Classiﬁcation methods
To evaluate the performance of SVDD method for disease gene
identiﬁcation, two other well known one class classiﬁcation meth-
ods, i.e. Guassian Mixture Model, and Parzen density estimation,
have been implemented in our study.Table 2
Comparison between sequence representation methods using all features.
Methods # of Feature Precision (%) Recall (%) F-measure (%)
AC-SVDD 180 74 76.2 75
GA-SVDD 180 77.3 79.5 78.3
NA-SVDD 180 70.9 82.4 76.2
MA-SVDD 180 69.8 79.7 74.4All the employed classiﬁers originate from the Matlab toolbox
ddTOOLS [42]. Each of these classiﬁers has its own parameters.
Parzen classiﬁer has a smoothing parameter s, and GMM has the
number of mixture components k of the positive class. While
SVDD has two parameters C, and kernel parameter a, where C is
the regularization parameter which controls the trade-off between
the volume of the hypersphere and the number of accepted train-
ing samples. We used trial and error to optimize the Parzen and
GMM parameters, and the values s = 0.38, and k = 29 were selected.
While, grid search has been carried out to optimize SVDD parame-
ters. Accordingly, the trained value of optimal kernel parameter as
well as the trained value of optimal regularization parameter are
a = 0.128, and C = 16, respectively.
The results of the estimation of precision, recall, and F-measure
scores are shown in Table 4. The results of precision indicate that
there is no signiﬁcant differences between the methods. While,
the analysis of the results of the recall scores clearly shows that
the SVDD method provides better performance than the other
mentioned methods. The signiﬁcant results of SVDD can be
explained as this classiﬁer prevents overﬁtting by utilizing only
few instances to support a boundary between disease genes and
other genes. While, for other methods like Parzen method, it takes
into account the information of all training samples. Hence, it leads
to more overﬁtting as well as more false negative rate.
Table 5
Comparison between disease gene identiﬁcation methods.
Methods Precision (%) Recall (%) F-measure (%)
Xu’s method (1) [6] 68.4 54.2 60.4
Xu’s method (5) [6] 66.8 56.3 61.1
Smalter’s method [12] 67.9 61.5 64.5
ProDiGe [14] 70.4 76.2 73.1
Proposed method (randomly negative data) 72.9 78.8 75.7
PUDI [15] 72.7 82.4 77.2
Proposed method (Likely negative data) 79.3 82.6 80.9
Fig. 4. The ROC curve of the test set as analyzed by PUDI, ProDiGe, Xu’s Method, and Proposed Method.
Table 6
Novel Disease gene predicted using SVDD algorithm.
Gene Score Phenotype
TRPV1 98.5 [42]
GP5 98.2 Thrombocytopenia [43]
Platelet disorder [44]
ANGPTL1 96.2 Melanoma [45]
Tumors [46]
BDNF 93.6 Huntington [47]
WSB1 92.8 Neurobalstoma [48]
TRPAL 88
PHLDA1 80.1 Tumors [49]
ODAM 79.6
ITGB1BP2 76.5 Hypertrophy [50]
EIF2AK2 69.3 Inﬂuenza [51]
Hepatitis c [52]
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We have compared the proposed method with the state-of-art
methods, including, Smalter’s method [12], Xu’s method [6],
ProDiGe method [14], and Yang method [15]. Table 5 shows the
comparison between the proposed method with other related
methods. The main differences between the proposed method
and the related ones are:
1. The prior-knowledge used to extract feature vector. In this
work, the sequence of protein as a more universal
prior-knowledge has been carried out, while in the previous
work, the prior-knowledge suffered from noise effect.2. The classiﬁcation method used for disease gene identiﬁcation
problem. All the previous methods consider this problem as
two class classiﬁcation problem. while, in this work the disease
gene identiﬁcation problem is treated as one class classiﬁcation
problem. The reason is that, there is no guarantee about the
negative instances which are extracted from unknown genes.
Therefore, it would be preferred to train the model using only
the positive instances.
To test our model, we have applied two types of negative data.
The First one, to reduce the noise data, we have attempted to select
some more likely negative data from unknown data; In this regard,
we selected the more farthest unknown data from the mean vector
of all positive data. The second type of negative data have been
randomly selected from all unknown data. We used the ﬁrst type
to make comparison with PUDI algorithm, while the second type
have been used to compare with the remaining algorithms. The
results indicate that the prediction performance of the proposed
method is better than the other ones.
To investigate how the proposed method can improve the per-
formance of disease gene identiﬁcation compared with the
state-of-the-art methods, we implemented the leave-one-out
cross-validation test and drew the ROC curves of the test set. As
shown in Fig. 4, the curve of the SVDD predictor shows higher pre-
diction performance on the whole range of false positive rates, and
produces an AUC score of 95.7%. While the AUCs achieved by PUDI,
ProDiGe, Xu’s Method, are 93%, 88.7%, 83.2% respectively. In other
Fig. 5. The ROC curve of Parkinson’s disease set based on PUDI, ProDiGe, Xu’s Method, and Proposed Method.
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false positives compared with other methods.
4.5. Novel gene identiﬁcation
We made an effort to discover novel disease genes that are not
available in the disease gene data set. In this regard, we employed
the positive data (disease genes) to train the model. Then, we
tested the model using other unknown genes. We selected the
top 10 genes based on their model likelihoods (SVDD probabili-
ties). By implementing the literature search, we found that 8 out
of 10 predicted disease genes are related at least with one disease.
Table 6 enumerates the novel disease genes which are predicted
[43–53].
4.6. Identiﬁcation speciﬁc disease class
To investigate the reliability of the proposed method in detect-
ing disease genes for speciﬁc disease classes, Parkinson’s disease
(PD) has been selected. We have obtained 32 PD-related proteins
from OMIM disease gene data. And 18 PD-related proteins based
on UniProt database [54]. We provided the dataset containing 100
samples. In this regard, the 50 PD-related proteinsmake up the pos-
itive data.While 50 unlabeled genes which have been selected from
likely negative set randomly, make up the negative data. To evalu-
ate the identiﬁer model, leave-one-out cross-validation test has
been performed. As shown in Fig. 5, the proposed method achieved
the area of 97% under ROC. While, the results of, Xu’s Methods,
ProDiGe, and PUDI are 91.4%, 93%, 95.2%, respectively. These results
indicate that the proposed method has good performance since it
can identify PD-related genes with high probability.5. Conclusions
In this article, we proposed a one class classiﬁcation based on
sequence of protein for disease genes identiﬁcation. GA represen-
tation method based on the physicochemical properties of amino
acids have been used to transform the amino acids sequences to
numerical feature vectors. Then, the more signiﬁcant features are
selected using PCA algorithm. Finally, we trained the model ofdisease gene using SVDD algorithm. The results demonstrate the
importance of solving the disease identiﬁcation problem as one
class classiﬁcation problem. In addition, it is worth to mention that
the physicochemical properties of amino acids would be highly
beneﬁcial. As comparison with other methods, we found that the
proposed method achieved better results than the previous stud-
ies. For future work, to achieve better classiﬁcation performance,
more physicochemical properties will be taken into consideration
such as amino acid composition, CC in regression analysis, and
graph shape index. To get better performance, we will also apply
a combination of different type of one class classiﬁcation methods.Conﬂict of interest
The authors declare that they have no conﬂict of interest.References
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